Emami Limited has accepted the resignation of Mr. Ravi Varma as Company Secretary and Compliance Officer, effective August 31, 2026. The company disclosed the change in a filing with stock exchanges on August 29, 2026.

Mr. Varma also ceases to act as the Nodal Officer of the company in compliance with Rule 7 (2A) of the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016.

Regulatory Disclosure

The disclosure was made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It also references SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Resignation Details

In his resignation letter dated August 28, 2026, Mr. Varma stated he chose to explore new opportunities for professional growth outside the organisation. He confirmed there were no other reasons for his departure.

Harsh Vardhan Agarwal, Vice Chairman and Managing Director, signed the intimation letter to the exchanges.

Emami Limited reported consolidated revenue of ₹1,039 crore for Q1FY27, marking a 15% year-on-year increase. Domestic business expanded by 20%, with like-to-like growth of 12%. The company declared total dividends of ₹436.5 crore for FY26 at its AGM on August 25, 2026.

The personal care and healthcare major navigated headwinds including an unseasonal summer and GST transition disruptions in FY26, yet delivered stable full-year revenue of ₹3,779 crore. For the current quarter, EBITDA rose 6% to ₹226 crore, while Profit Before Tax grew 4% to ₹195 crore, reflecting cost management discipline amid rising crude oil and packaging costs.

What the Numbers Show

A divergence between top-line and bottom-line performance in Q1FY27 highlights margin pressure. While revenue surged 15%, EBITDA growth was more modest at 6%. This gap suggests that gross margins faced headwinds from higher input costs, specifically crude oil and packaging inflation, as explicitly noted by management. Despite this, the company maintained profitability through operational efficiency.

Strategic Investments and Portfolio Shift

Emami’s strategic investment portfolio is scaling rapidly. In early FY27, the company acquired majority stakes in Axiom Ayurveda (AloFrut) and IncNut Digital (Vedix, SkinKraft). These investments contributed 6% of consolidated turnover in FY26 and are expected to reach 16% in FY27, with a long-term target of 25% by FY30.

Domestically, the business mix is shifting toward non-seasonal categories. Non-seasonal products now contribute 56% of domestic business, up from 50% in FY20. New-age and mainstream brands grew from 7% to 21% of domestic sales over the same period, reducing reliance on seasonal talc products.

Financial Position and Dividends

The company remains virtually debt-free with a debt-equity ratio of 0.04x and a net cash surplus of ₹883 crore as of March 31, 2026. Return on Equity stood at approximately 30% for FY26. The Board declared interim dividends of 1000% (₹10 per equity share), continuing its multi-decade track record of shareholder payouts.

International Business Resilience

International operations, spanning over 70 countries, contributed 18% of consolidated revenue in FY26. Growth moderated to 3% for the full year due to West Asia conflict-related disruptions in shipping and freight costs, down from an 8% run rate earlier in the year. The region-wise split includes 41% from MENAP, 40% from SAARC & SEA, 12% from CIS, and 7% from Africa & Others.

Digital and Sustainability Initiatives

Digital media now accounts for more than 50% of total Above-the-Line (ATL) investments, up from 20% in FY22. Three key digital transformation projects—Project SETU, SalesCode.AI, and the Analytics Hub—are on track for completion in FY27. On sustainability, Emami reduced energy consumption by 21% and water consumption by 53% since FY22, with renewable sources accounting for 21% of energy requirements in India operations.